- -

Big Pharma, Little Science? A bibliometric perspective on big pharma's R&D decline.

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Big Pharma, Little Science? A bibliometric perspective on big pharma's R&D decline.

Show full item record

Rafols García, I.; Hopkins, M.; Hoekman, J.; Siepel, J.; O'hare, A.; Perianes-Rodriguez, A.; Nightingale, P. (2014). Big Pharma, Little Science? A bibliometric perspective on big pharma's R&D decline. Technological Forecasting and Social Change. 81:22-38. doi:10.1016/j.techfore.2012.06.007

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/62835

Files in this item

Item Metadata

Title: Big Pharma, Little Science? A bibliometric perspective on big pharma's R&D decline.
Author:
UPV Unit: Universitat Politècnica de València. Instituto de Gestión de la Innovación y del Conocimiento - Institut de Gestió de la Innovació i del Coneixement
Issued date:
Abstract:
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characterised by stagnation in the numbers of new drug approvals in the face of increasing R&D costs. This study explores pharmaceutical ...[+]
Subjects: Pharmaceuticals , Bibliometrics , Outsourcing , Europe , Globalisation , Research network , Innovation , Collaboration
Copyrigths: Reserva de todos los derechos
Source:
Technological Forecasting and Social Change. (issn: 0040-1625 )
DOI: 10.1016/j.techfore.2012.06.007
Publisher:
Elsevier
Publisher version: http://dx.doi.org/10.1016/j.techfore.2012.06.007
Type: Artículo

This item appears in the following Collection(s)

Show full item record